background: In New Zealand ranking patients for elective, publicly funded procedures uses clinical priority access criteria (CPAC). A CPAC to prioritize patients seeking assisted reproductive technology (ART) was developed in 1997 and implemented nationwide in 2000. This study describes the development of the ART CPAC tool and its evaluation on 1386 couples referred to a single tertiary service from 1998 to 2005.
Introduction
In New Zealand ranking patients for elective, publicly funded, procedures uses clinical priority access criteria (CPAC) that were introduced in the mid-1990's for several procedures (Hadorn and Holmes, 1997; Gauld and Derrett, 2000) . This followed a government policy change where waiting lists were abolished for elective surgery and replaced by a system where patients would be booked for operation at the time of specialist assessment. The purpose of the CPAC system was to allow better management of limited health resources, provide transparency and consistency to decisions relating to treatment, provide certainty to patients and make clear the demand for elective medical services (Gauld and Derrett, 2000) . Eligibility for treatment was to be determined in accordance with predetermined standards. Criteria were developed based on both the patient's need for treatment and their ability to benefit, while ensuring social values were included in the prioritization process.
Development of a CPAC for infertility services was a natural consequence of the government initiative since, in the 1990s, there was wide variation in access to publicly funded infertility services particularly assisted reproductive technology (ART). A CPAC to prioritize patients seeking ART was developed by two of us, presented to the National Health Committee in 1997 (Gillett and Peek, 1997) and implemented nationwide in 2000.
CPAC use in elective surgery has not always matched clinical opinion in selecting which patients would benefit the most from treatment (Derrett et al., 2003) . Clinician acceptance has varied, both in the way patients are scored and in the impact of the score on scheduling patients for surgery (MacCormick et al., 2004; Dew et al., 2005) . A common criticism was that the CPAC does not reflect clinical judgment. Gaming, a process where clinicians elevate the score to ensure a patient receives treatment, has been common (MacCormick et al., 2004) .
The aim of this study is to describe the development of the ART CPAC tool, and to evaluate it against the goal of identifying those most likely to benefit from treatment by following its use by 1386 couples referred to a single clinic from 1998 to 2005. The evaluation did not include clinician, patient or government satisfaction with the scoring tool.
Materials and Methods

Development CPAC
Step 1 In 1997 invitations to participate in developing the criteria were sent to the six centres offering IVF and the consumer organization the New Zealand Infertility Society (now fertility NZ). The initial letter sought advice on what criteria should be included in the CPAC. Respondents were asked to nominate 10 criteria and rank them in order from most to least preferred. A value was assigned between 10 and 1 to reflect this rank order. Forty-eight responses were received and the lists collated by combining all ranking points. Responses were received from 25 IVF professionals, 20 consumer representatives and 3 health administrators.
Twenty-two separate criteria were nominated. The four highest ranked criteria were duration of infertility, the couple's diagnosis, woman's age and number of children and these were accepted for inclusion. Some relatively high ranking suggestions for criteria were excluded because they did not fit with government policy, such as ability to self-fund treatment, or because they were too difficult to measure, such as stability of the relationship.
Three additional criteria were initially selected, being sterilization status, woman's smoking status and basal FSH level. Sterilization status arose because respondents thought couples embarking on a second family after voluntary sterilization had less call on public spending than those who had not had sterilization. The woman's smoking status and basal FSH status criteria were considered because they were related to the chance of success with ART treatment. However, smoking was later made an exclusion criterion so that couples could only be scored if the woman stopped smoking, and as egg donation became more accessible, FSH was changed from a criterion for access to directing whether own or donor eggs should be used.
To satisfy the National Health Committee's directive that criteria should identify a couple's need for treatment and the ability to benefit (Gauld and Derrett, 2000) the five selected criteria were divided into two groups. Three 'social' criteria (duration of infertility, number of children and sterilization status) to measure social values and two 'objective' criteria (female age and diagnosis) to identify patients who were most likely to benefit from treatment. Ability to benefit meant public funding would be used when a woman was able to conceive with treatment and not used when the woman was able to conceive without treatment.
Step 2 social criteria
The three social criteria were combined to give a total of 100 points. The contribution towards the 100 points was derived from the ranking of the criteria in Step 1. The next step was to categorize the criteria and give weights to each category. Categories for duration of infertility and number of children were sent to the 48 participants to undertake a utility analysis. Values were derived using magnitude estimation within multiattribute utility theory (Boyle and Torrance, 1984) . Magnitude estimation places no constraints on the size of response available to raters. All participants were given a practice so they understood the process before assigning their final values. Briefly, with each criterion the respondent first assigned an order of the least preferred to most preferred category within the criterion. Beginning with 10 points for the lowest ranked category the respondent assigned a higher value to the next category that reflected the relative worth (as a ratio) between the two. Each category was taken in turn to assign a number that reflected the relative worth between each level, rechecking the relative ratios with other levels if necessary. Relative weights were converted to a 100-point scale.
Step 3 objective criteria Each of the two objective criteria was assigned up to 10 points. For woman's age, points were based on birth rates from New Zealand's largest IVF clinic (Fertility Associates) from 1987 to 1996, being ≤35 ¼ 10 points, 36 -37 ¼ 7, 38 -39 ¼ 4, 40-41 ¼ 2, 42 + ¼ 1.
At the time of the CPAC development, there was limited evidence of how to relate grading of diagnosis to prognosis without treatment (The ESHRE Capri Workshop, 1996) . A classification was developed for six diagnoses with the hypothesis that a specific diagnosis can be classified to reflect severity, and that the probability of spontaneous pregnancy will diminish with more severe disease. This classification was based on the American Society for Reproductive Medicine classification of endometriosis (American Society for Reproductive Medicine, 1997) . Even though the endometriosis classification was developed to predict the probability of pregnancy following treatment, it also assumed that more severe disease had less chance of a spontaneous pregnancy (Olive et al., 1985) . Tubo-peritoneal infertility was classified by the predominant pathology on the best side adnexa and the best side was defined as the adnexa with the least pathology. Classifications for other causes were developed using clinical judgment.
The diagnostic model also recognized the importance of a combination of multiple infertility factors on prediction of spontaneous pregnancy (Jansen, 1993) . Each classification was scored (6, 3, 2, 1 and 0) and a final diagnostic score (DS) obtained by combining all individual scores (Fig. 1) . A couple's diagnosis was classified as severe (DS ≥ 6), moderate (DS ≥3 , 6), mild (DS ¼ 2) or minimal (DS ¼ 1). The DS (1-6) in turn was used to assign points (2, 4, 7 or 10) for diagnosis. The weighting of these points reflected the anticipated prognosis without treatment, the chance of spontaneous pregnancy being estimated as ≤5% in 2 years for a severe diagnosis though to .50% for minimal diagnosis (Gillett and Peek, 1997) . Figure 1 The CPAC tool and its calculation.
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Step 4 the CPAC score
The overall CPAC score was calculated in three steps (Fig. 1) . The two objective points O1 and O2 were multiplied on the assumption that they acted independently on the chance of pregnancy, and then divided by 100, to obtain the objective score (OS). The three social points S1 -S3 were summed to obtain the social score (SS). The final score was obtained by multiplying OS by SS.
Step 5 public submissions Prior to implementation a document describing the infertility CPAC (Gillett and Peek, 1997) was put for public consultation by the National Health Committee. Forty submissions were received from IVF clinics, other health groups, community organizations and consumer groups including the New Zealand Infertility Society. Five submissions did not support the criteria, either because they felt the proposed system was unfair or because they opposed public funding of infertility services. The majority supported the criteria with most concern about access being reduced if the woman was aged 36 or more. Following discussion with the Ministry of Health, and with subsequent improvements in pregnancy rates in women age 36 -39, the age subcategories and points were changed: ,40 ¼ 10, 40-41 ¼ 5, ≥42 ¼ 1.
Evaluation of the CPAC
The Otago Fertility Service (OFS) in Dunedin Hospital is the sole provider for secondary and tertiary infertility services in the lower South Island of New Zealand (population 300 000). From 1998 to 2005, all new patients had a CPAC score calculated from clinical information entered into a spreadsheet. A score was assigned at the first assessment and at yearly intervals up to 5 years. As diagnostic information became available the scores were adjusted automatically for all time intervals. The spreadsheet was also used to monitor treatments and outcomes.
The OFS completed an assessment for all referrals based on guidelines established by the New Zealand Ministry of Health (Gillett and Peek, 1997) . This included a full history and examination of both partners, health screening tests for the female partner, evaluation of the menstrual cycle and at least one semen analysis. If there was one abnormal semen analysis it was repeated in the OFS laboratory and swim-up and antisperm antibody tests performed. The preferred method for evaluating tubal factor infertility was laparoscopy that was performed after 3 years duration of unexplained infertility or if medical history deemed an earlier assessment necessary (Gillett and Peek, 1997) . Women aged ≥30, were eligible for laparoscopy after 18 months. Women aged ≥40 were not eligible for publicly funded laparoscopy.
A withdrawal date from the programme was recorded for each case, this being either the date a woman was known to have conceived (providing the pregnancy continued to birth) or the date a couple withdrew for other reasons. Pregnancies included spontaneous and treatment-related pregnancies. Other reasons included elective withdrawals from the programme after completed failed treatment, withdrawing without undergoing treatment, couples who separated, couples who moved to another region and couples lost to follow-up. If no date was available for a withdrawal then the last date seen at the clinic was used. Treatment commencement dates, the type and number of treatments and whether funded publicly or privately were recorded.
Statistical analysis
With the CPAC development comparison of ranks and utility scores between consumers and professionals used analysis of variance with post hoc comparisons by Duncan's multiple range test (a ¼ 0.05).
For the CPAC to be an effective tool, it needed to differentiate those who were more likely to conceive on their own and those who were less likely. To assess whether this was achieved couples were grouped as to their eligibility for funded ART: Group 1 (eligible at 0-1 year from first assessment), Group 2 (eligible .1 -5 years) and Group 3 (never eligible). For simplicity, we use the term 'spontaneous' pregnancy to mean treatment-independent pregnancy. The rate of spontaneous pregnancy was evaluated using Cox's proportional hazards regression, with Group 3 cases as the reference. As treatment and treatment-related pregnancies would have influenced spontaneous pregnancy the models were also run with these events as a competing risk (Fine and Gray, 1999) . A competing risk is an occurrence that stops the person having the event of interest. Thus having a treatment-related pregnancy means that a spontaneous pregnancy is impossible although it may have happened if the treatment-related pregnancy did not occur. Modelling also included spontaneous pregnancy as a competing risk after starting treatment. This was to accommodate the possibility that a treatment might influence the probability of a spontaneous pregnancy, even though that treatment had been withdrawn [e.g. ovulation induction (OI) or IVF].
The success of a CPAC model depends on its ability to recognize people who will succeed with treatment. Group 3 was divided further into Group 3a being women aged ,40 and Group 3b being women aged ≥40. Groups 1, 2, 3a and 3b were evaluated by Cox's proportional hazards regression using the time to treatment dependent live birth pregnancy, the reference being Group 1. The analysis included all treatments that required a CPAC score and was adjusted for couples commencing with private or public treatment. For this analysis, it was recognized that in couples who were sterilized their inclusion would have misled the impact of treatment on other conditions. Since reversal cases have a duration starting from the first specialist assessment, and also have fewer points by the sterilization criteria, many of these cases were in the never eligible group. Live birth pregnancy rates were high for reversal surgery (27/34 for female reversal and 9/18 for male reversal) so all cases with reversal procedures were excluded.
Since the CPAC score used a theoretical diagnostic model its validity was evaluated separately. Even though a DS .6 did not add further to the diagnostic points in the CPAC scoring system, for analysis the diagnostic groups were extended to six: minimal, mild, moderate, severe (≥6,12), very severe (≥12) and a combined severe group where a score of ≥6 was derived from the combination of minimal, mild and moderate classifications only. The hypothesis was that increasing severity as measured by the scoring system would incrementally reduce the chances of spontaneous pregnancy. The groups were evaluated by Cox's proportional hazards regression, with Group 1 as the reference, using the time to spontaneous pregnancy and adjusted for age at referral. Competing risk analysis was also performed as described above.
All survival analyses with Cox's proportional hazards regression were illustrated using Kaplan-Meier graphs.
IVF was the predominant treatment offered and evaluation of IVF use was made across each of the three eligibility groups. Cumulative live birth rates for women age ,35, 35 -39 and 40+ were examined by survival analysis, with comparison between groups using the Wilcoxon test.
SPSS for Macintosh version 19.0 was used for all analyses, except competing risk analysis that used Stata version 11. Table I lists the three selected social criteria, mean rank, the relative weight on a 100-point scale and the final allocated points. Mean ranks for IVF professionals and consumers were similar. Twenty-eight respondents completed the utility analysis. In none of the subcategories were utility values statistically significantly different between the 10 consumers and 15 IVF professionals completing the analysis. Table II describes the subcategories, mean utility values and the final allocated points.
Results
Development of CPAC
Social criteria
The sterilization criterion was not included in the utility analysis. Twenty points were allocated as the maximum, to be allocated to non-sterilized people or if a loss of a child occurred following sterilization. If either partner was sterilized 10 points were awarded.
Implementation
When developing the CPAC model, we modelled the proportion of couples eligible at various threshold scores (Gillett and Peek, 1997) . Given the level of funding at the time a score of 65 points was advised as the expected threshold. The Ministry of Health ultimately set the treatment threshold at 65 and limited access to one 'package' of treatment. A package of treatment was one IVF cycle including the replacement of all embryos from that cycle, surgery for tubal anastomosis or vasectomy reversal, or four cycles of IUI, donor insemination or OI using gonadotrophins. OI with clomiphene was outside the CPAC system. Other surgery (e.g. endoscopy for the treatment of endometriosis) was covered by a separate gynaecology CPAC.
Where one partner was sterilized the duration of infertility began from the date of the first specialist assessment. Single and lesbian women could access public funding if they had biological infertility, or if they failed to conceive after 12 cycles of donor insemination treatment, 6 of them needing to be in an ART clinic.
Couples beneath the treatment threshold were placed on active review, the review being the date the CPAC score was calculated to reach the treatment threshold (achieved by increasing duration of infertility). Couples on active review could elect for private treatment during this period. Couples where the woman's BMI was outside the range of 18-32 kg/m 2 were excluded, placed on active review and were enrolled when the BMI fell within the acceptable range. Couples on active review were advised of measures that would enhance their chances of spontaneous pregnancy e.g. weight loss, regular and well-timed intercourse. In some Group 3 cases (never eligible) treatment was offered. This discretion, also available to couples on active review, is known as clinical override and fertility clinics were advised they could use this to a limit of 5% of all publicly funded ART cycles. Clinical override was used when CPAC scoring could not take all clinical or social factors into consideration-for instance to treat women with progressive endometriosis who would otherwise need to wait to accumulate points from a longer duration of infertility and this would make pregnancy increasingly unlikely.
The treatment threshold has remained set at 65 since its inception. A higher demand in some areas was met by additional funds to ensure a nationally consistent threshold was retained. In other areas patients have needed to wait for longer than the target of 6 months. In 2005 the government increased the level of funding and, rather than reducing the threshold, a second package was offered to couples if they did not have an ongoing pregnancy from the first package, so long as they still had a CPAC score above the threshold. This was backdated for couples having their first cycle from 2003. The funding for the second package partly came from anticipated savings in obstetric and neonatal care arising from compulsory single embryo transfer in women aged 35 and younger (with some conditions). The reference being the final allocated points in Table I.   b The numbers needed to reflect easy to use numbers.
Prioritizing for publicly funded assisted reproduction 2001-2004.) . To improve its ease of use two of the six diagnostic criteria, ovulation disorders and semen defects, were slightly modified to ensure easier interpretation. These are described in a recent study comparing ART in New Zealand and Australia (Farquhar et al., 2010) .
Evaluation of the CPAC
In the period 1563 referrals were made to the OFS. New entries ceased at the end of 2005 and the data set closed at the end of 2010 by which time all but 21 couples had finished treatment. Lesbian (22) and single women (30) and couples referred for a second time (125) were excluded in the subsequent analysis. Table III describes characteristics of the 1386 couples categorized by their eligibility for funded ART, and outcomes of the 915 couples who elected and started treatment and the 471 who did not. Those eligible at or within a year of referral (Group 1) had longer duration of infertility, fewer children and had more severe diagnosis for their infertility. Four hundred and eighty couples had at least one IVF treatment, 404 (84%) having a publicly funded treatment. Two hundred and fifty-one couples used IUI or donor insemination, 114 had IUI or donor insemination alone. In contrast to IVF, 76% of couples using IUI or donor insemination funded it privately, including 63% Group 1 cases. This reflected the wish for couples to keep their public funding for the more expensive IVF.
A total of 762 (55%) women gave birth, 473 from treatment and 289 spontaneously. Group 1 had more pregnancies from treatment and Group 2 had most pregnancies overall, these were derived mainly from spontaneous pregnancies.
Clinical override was applied to 55 couples, being 9.3% of those having any form of ART. Nine were in Group 3 (never eligible), eight were age 37 -39 and one woman was 40. Of those receiving treatment through clinical override 29 (53%) conceived with treatment, and 2 had a spontaneous pregnancy.
One hundred and forty-five Groups 1 and 2 couples who requested and were eligible for public ART (mostly IVF) did not undertake public treatment. Seventy-one of these elected and completed private ART and did not proceed to public treatment and 74 cases who initially elected public ART did not start this or any other treatment. Table III explains the reasons for their withdrawal.
Four hundred and eighty couples started IVF treatment that went to oocyte pick up (OPU), 207 had two OPU cycles and 70 had three. The cumulative probability (SE) of a live birth pregnancy was 0.36 (0.02), 0.61 (0.03) and 0.73 (0.04) after 1, 2 and 3 cycles respectively; where a cycle included using any available frozen embryos to achieve the pregnancy. For women aged ,35, 35-39 and 40+ at the first IVF treatment, the three OPU cycle cumulative probability (SE) of a live birth pregnancy was 0.77 (0.03), 0.68 (0.06) and 0.43 (0.14), respectively (Wilcoxon 15.5, df ¼ 2, P , 0.001). Figure 2A -C use Kaplan -Meier graphs to illustrate the ability of the CPAC scores to differentiate the chance of pregnancy with and without treatment. Figure 2A describes the cumulative spontaneous pregnancy rates for the three eligibility groups. Compared with Group 3 cases (never eligible), the hazard ratio using the time to spontaneous live birth pregnancy for Group 1 couples was significantly lower [0.51, 95% confidence interval (CI) 0.36 -0.74, P , 0.001] and for Group 2 cases significantly higher (1.86, 95% CI 1.35-2.58, P , 0.001). Adjusting for competing risk did not change hazard ratios significantly. Figure 2B describes the cumulative pregnancy rates with any ART. Compared with Group 1 cases (n ¼ 409) hazard ratios using time to treatment dependent live birth pregnancy were similar for Groups 2 and 3a and lower for Group 3b: Group 2 (n ¼ 139), 0.86, 95% CI 0.66 -1.13, P ¼ 0.8; Group 3a (n ¼ 35), 0.74, 95% CI 0.43 -1.28, P ¼ 0.7; Group 3b (n ¼ 39) 0.37, 95% CI 0.14 -0.90, P ¼ 0.03. Commencing with private treatment, n ¼ 265, did not improve the time to pregnancy compared with starting with public treatment, n ¼ 357, (hazard ratio 1.12, 95% CI 0.89 -1.41, P ¼ 0.36). Figure 2C describes the cumulative pregnancy rates for the different diagnostic groups confirming that increasing severity reduced the chance of spontaneous pregnancy. Compared with the minimal diagnosis group (n ¼ 147) hazard ratios using the time to spontaneous live birth pregnancy were significantly reduced for all other diagnostic categories: mild (n ¼ 116), 0.42 (95% CI 0.28 -0.61, P , 0.001); moderate (n ¼ 308) 0.35 (95% CI 0.26 -0.47, P , 0.001); combined severe (n ¼ 109), 0.23 (95% CI 0.14 -0.36, P , 0.001); severe (n ¼ 573), 0.09 (95% CI 0.06 -0.13, P , 0.001) and very severe (n ¼ 130), 0.05 (95% CI 0.02 -0.11, P , 0.001). Adjusting for age did not change hazard ratios significantly. The analysis adjusting for competing risk did not change hazard ratios significantly.
Discussion
This study confirms the CPAC as an important tool in directing couples to publicly funded ART. Couples with a lower chance of spontaneous pregnancy received early funded treatment, while couples with a higher chance of spontaneous pregnancy were placed on active review until their CPAC score increased. Couples who could make lifestyle modifications such as ceasing to smoke or lose weight were also placed on active review. Even though entry to ART was guaranteed for Groups 1 and 2 cases many elected to have private ART in the active review period. That pregnancy rates were similar for those who commenced private and public ART is to be expected, since both groups had a good prognosis with treatment. Those who were required to wait for eligibility for public treatment were in that position because the chance of spontaneous pregnancy was judged to be relatively high, not because the chance of treatment-dependent pregnancy was judged to be low.
The study achieved a major goal in being able to discriminate between those offered and not offered treatment. It also confirmed the DS as an objective measure of prognosis. In particular, couples with a minimal, mild or moderate DS were given time to achieve pregnancy without resorting to ART. Although consumer anxiety and distress at delay in treatment is expected these data support a recent simulated study that confirmed conservative treatment in unexplained infertility would result in cumulative pregnancy rates equivalent to early IVF (Stanford et al., 2010) .
Our view is that the CPAC scoring system developed here codified good clinical judgment although there remained some difficult exceptions, principally involving women in their late 30's who have at most moderate factor infertility. In this situation clinical override was available when it was deemed clinically appropriate. Communication (79) 259 (57) 149 (51) 915 (66) Mean (SD) time to first treatment (months) 8 (10) 7 (10) 6 (11) 7 (10) Mean (SD) time to IVF commencing (months) 14 (13) 24 (16) 14 (13) 16 (14) Mean ( Cases having public IVF only 254 (50) 57 (22) 12 (8) 323 (35) Cases having both public and private IVF 62 (12) 17 (7) 2 (1) 81 (9) Cases having private IVF only 26 (5) 19 (7) 31 (27) 76 (8) Outcome of couples having publicly funded IVF Conceived with public IVF 149 (47) 37 (50) 5 (36) 191 (47) Conceived from private IVF that followed public IVF 20 (6) 5 (7) 0 25 (6) Conceived spontaneously following IVF 13 (4) 3 (4) 1 (7) 17 (4) Finished IVF without a child 92 (29) 24 (32) 8 (57) 124 ( (52) 146 (56) 63 (42) 473 (52) Conceived spontaneously 34 (7) 34 (13) 12 (8) 80 (9) Finished treatment and withdrawn 123 (24) 45 (17) 56 (38) 224 (25) Lost to follow-up during treatment 72 (14) 30 (12) 15 (10) 117 (13) Still in treatment in 2011 14 (3) 4 (2) 3 (2) 21 (2) Cases who did not start treatment 136 (21) 192 (43) 143 (49) 471 (34) Outcome of couples not starting treatment 2001-2004.) . Clinical override may reflect some gaming but in our view it was used to compensate for gaps in CPAC system. When the threshold is set at 65, there is a particular problem with some couples with unexplained infertility or a combination of mild factors staying on 63 points for 2 years before their duration reaches 5 years. The ability to direct people to earlier treatment is an important clinical option since with delay in ART treatment would have a reduced efficacy. We intend to use our data set of OFS patients to examine other models that might reduce the need for override. The driver for clinicians embracing the CPAC was that New Zealand IVF clinicians saw it as tool to ensure consistency in provision of services and equity of access. It is not clear if geographical equity has been achieved since these data are not available. However from the experience at OFS the CPAC did allow couples to plan and manage their future, knowing with certainty if and when funding would be available. The CPAC model may have contributed to higher IVF pregnancy and live birth rates in New Zealand compared with Australia, with the suggestion that using the CPAC tool resulted in women better able to benefit from IVF being offered treatment compared with those in Australia (Farquhar et al., 2010) .
Using the OFS data set of clinical information, the next phase of this evaluation will be to model different scoring options to examine the size of benefit with each. Different weights may produce different ranking of patients. For couples with unexplained infertility, a model developed in the Netherlands (the Hunault model) was better in some aspects than the CPAC tool in predicting spontaneous conception (Farquhar et al., 2011) . That many not eligible became pregnant with treatment in that study and ours indicates better selection might be possible. There remains the difficult problem of couples needing to wait for treatment. As women wait the efficacy of treatment will wane. Even though clinical override helps in early treatment, the tool would be better if this was a feature rather than an exception.
Improvements in delivering public funding may also come about from improvements in diagnosis and treatment such as anti-Müllerian hormone testing, blastocyst culture and embryo vitrification. For example, blastocyst culture has the capacity to improve the efficiency of treatment and may enable more people to be treated for the same expenditure. It is unlikely that such improvements will change the relative success rates for different groups of patients and hence change the basis of CPAC scoring. That New Zealand had a robust CPAC in place brought additional government funding for preimplantation genetic diagnosis, access being controlled by the existing CPAC tool.
Eligibility criteria for infertility services in other countries
Regulation, provision and funding of IVF differ widely throughout the world (Chambers et al., 2009; Simonstein, 2010) and we are aware of only two published eligibility criteria that give explicit advice to guide publicly funded ART (Expert Advisory Group on Infertility Services in Scotland, 1999; Lindstrom and Waldau, 2008) . In England and Wales, the NICE criteria guide public access to ART (NICE, 2004) but there is still a lack of consensus about the criteria used (Kennedy et al., 2006) .
In Scotland, criteria were introduced in 2000 with the recommendation they be applied nationally across all Scottish Health Boards (Expert Advisory Group on Infertility Services in Scotland, 1999). Five criteria were listed that couples needed to satisfy in order to receive treatment. These included female age ,38 years, no children and an appropriate diagnosed cause or unexplained infertility of at least 3 years. A 2005 review of the use of these criteria identified inconsistencies in how they were applied across the Health Boards. A recommendation was made to extend the woman's age limit to ,40 (The Scottish Executive, 2005) . In Sweden criteria were established for one region, and included criteria based on effectiveness, BMI 18 -30 kg/m 2 , basal FSH ,10 and female age 23-36 (Lindstrom and Waldau, 2008) . In couples with unexplained infertility of 3 years access was only possible in women younger than 32 years. Social criteria included childlessness, but only one partner needed to be childless. A disadvantage of using dichotomous inclusion criteria as in Scotland and Sweden is that adjustments may not be easy without reconfiguring the criteria. The New Zealand CPAC allows incremental changes in funding (up or down) without needing to change the scoring system or criteria. We contend that using a score such as ours is much easier to administer.
Strengths and limitations of the study
Using the opinions of experts and non-experts rather than scientifically derived information in the development of the priority criteria was a potential weakness of the criteria. Apart from the known impact of increasing age with reduced reproductive performance and the impact of smoking, there were no evidence-based data involved in the CPAC development. When introduced in the 1998, our intent was to collect and assess information that would assist validation of the criteria. That the OFS is a small centre meant that recruitment for the study was extended over 8 years, and follow-up for another 5 years before almost all cases had come to the end of their infertility journey. We believe that clinical standards did not change significantly in this time. Nevertheless, the study relied on including all patients referred to the clinic, including couples who were at a secondary care level and may not have anticipated using ART. The study may therefore not reflect practice elsewhere. The strength of the ART CPAC was that all but one criterion (DS) was derived from easily interpreted clinical information. Therefore gaming that has been an issue with the surgery CPAC tool ought to be less likely. The DS required subjective assessment of clinical information, and was a theoretical model only. All cases categorized as severe had immediate public access providing the woman was under 40 years of age and neither partner had been sterilized. We were encouraged that the level of severity correlated well to the chance of spontaneous pregnancy and suggests the DS was robust.
Duration of infertility, although an objective measure as reported by the patient, required honesty from the couple or the referring practitioner. To our knowledge overt misleading information was not seen. A novel aspect was the inclusion of duration of infertility for all couples as a diagnostic criterion whether or not there were other causes, such as male infertility or tubal factors. If we think of unexplained infertility as infertility of unknown cause, then duration becomes a measure of possible contribution of unknown causes.
A weakness of the diagnostic classification is that it can be open to too much variation in interpretation. This variability is well documented for endometriosis (Guzick et al., 1997) and will almost certainly apply to the other categories. In the Dunedin cohort only two clinicians contributed to diagnosis, and so the variation was minimized. However the reliability of the diagnostic scoring was never formally assessed, apart from having regular discussion of difficult cases with the two clinicians involved to give an agreed diagnosis. At the national level aspects of the DS provided ongoing discussion, and there was an occasional need for clinicians to meet to reach a consensus. Subcategories of ovulation disorders and semen defects, were modified to ensure easier interpretation, the former, in particular, was a pragmatic solution that incorporated management outcomes to simple treatments and to avoid variability in interpretation.
The age criterion was the only criteria that caused considerable disquiet in the public submissions that preceded the introduction of the CPAC. The main argument was that older women had the most urgent need. The original tool gave highest priority to women aged ≤35, but even the modification to age ,40 meant older women would miss out. A treatment threshold of 50 points was commonplace among the providers of other CPAC tools at the time, and if introduced at this level then women under 42 years of age would have had access. In Sweden, cost-effectiveness was the guiding principle at setting the age criteria at ≤37 (Lindstrom and Waldau, 2008) . In the UK, the NICE guideline advises the optimal female age for IVF is 23 -39 (NICE, 2004) , and there is wide clinician support for this (Kennedy et al., 2006; Maheshwari et al., 2008) .
The social criteria were introduced as a rationing process, since objective criteria alone would not alone provide sufficient reduction in the number of eligible couples to match available funding. Couples with the highest priority were childless, had a duration of infertility of 5 years and neither had been sterilized. To enable more than one child per family was an important consideration and couples with at least one child were given access to funding but with a lower weight. Unfortunately, the funding rules meant that this Prioritizing for publicly funded assisted reproduction did not apply to couples having had one child through publicly funded ART, and the government has not responded to a strong recommendation to remove this barrier. Needing a duration of 5 years where there is unexplained infertility may also seem unfair but couples in this situation still have a chance of spontaneous pregnancy. A history of sterilization need not deny access and immediate access was possible for exceptional cases such as loss of a child, although this was not needed in the OFS data set.
Conclusions
We have described the development and evaluation of a scoring tool that directs publicly funded ART treatment. Over an 8-year period 1386 infertile couples from one IVF centre were scored using the tool and all but 21 followed for the duration of their infertility. Using a treatment threshold directed by the Ministry of Health the CPAC identified couples who were most likely to be benefit from ART treatment. It also allowed good prognosis cases time to enable resolution of their infertility therefore allowing good use of scarce public funds. We have a data set that will enable further evaluation of the tool to assess if a different construct might produce a better selection process. Although other elective services in New Zealand (principally directed for elective surgery) have found difficulties with the use of the CPAC tools, the IVF Directors have found the use of the ART CPAC easy to administer since it uses clinical information that is easily interpreted. A major advantage of a scoring CPAC is that the treatment threshold may be changed to match funding. The need to change the threshold has not yet been exercised for ART.
In a recent review, Devroey et al. (2009) looked forward to personalized modelling to improve fertility treatment outcomes for individuals. The CPAC tool described here is a practical step in deciding access to fertility treatment that is outcome-based when there are limited resources, achieving Devroey et al.'s goal for the population if not always for an individual.
A BMJ editorial in 1999 suggested that a priority scoring system may benefit the UK NHS (Edwards, 1999) , but as far as we are aware, a decade on, no scoring system exists. In England and Wales a review of the NICE guideline is to be published 'not before 2012' (Macbeth and Rutherford, 2010) . Given our experience with the ART CPAC and its validity we encourage others to develop it for use in providing transparency for infertile people and ensure equity of access. Our CPAC need not be the one that is used but it stands as a useful model to allow others to develop criteria that reflect variation in practice in other countries. Table S1 is a supplementary file in the online version of this article. It is an example of one respondent's utility analysis.
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